First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial
Eichhorst, Barbara, Fink, Anna-Maria, Bahlo, Jasmin, Busch, Raymonde, Kovacs, Gabor, Maurer, Christian, Lange, Elisabeth, Köppler, Hubert, Kiehl, Michael, Sökler, Martin, Schlag, Rudolf, Vehling-KaiseLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(16)30051-1
Date:
May, 2016
File:
PDF, 544 KB
english, 2016